Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


30. December 2020 | 09:29 CET

Everfuel, Q&M Dental Group, SAP - Focus on change!

  • Investments
Photo credits: pixabay.com

The year is drawing to a close. It has been an exciting year for the capital markets due to the Corona pandemic. In addition to reaching new highs at Dow, DAX & Co., the boom in IPOs, especially in the USA, was another surprise. The situation in the real economy is different, though. While Europe, South America and the United States are still suffering from the lockdowns, the Asian economies are recovering far faster than expected.

time to read: 3 minutes by Stefan Feulner


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


New lifestyle

Without question, Asia has come through the Corona pandemic best so far. Economies, especially in Southeast Asia, have been growing rapidly for years, as have employee wages. As a result, the new, more expensive standard of living of the emerging middle class boosts consumption. Besides the strong demand for foreign travel and consumer goods, Asians are particularly keen to invest in health and beauty. In the fast-growing dental aesthetics and dentistry market, Singapore-based Q&M Dental Group is a major beneficiary of this trend.

Founded in 1996, the Company is a leading private dental group in Asia and the largest private dental service provider in Singapore. The group operates 114 dental offices, 5 medical clinics, 3 dental supplies and equipment distribution companies in Singapore, Malaysia and China. With the help of 230 dentists and over 400 employees, Q&M Dental Group serves more than 600,000 patients.

Research with artificial intelligence

Already well advanced in the area of research is the development of a platform with the help of artificial intelligence. The Q&M Dental Group is cooperating with AI Singapore and a team from the International Medical University in Malaysia. The clinical data that Q&M has collected over the years will be combined with dentistry's latest research on the platform. As a result, the patient's underlying disease can be identified quickly, and the most appropriate treatment method suggested.

Further growth as a goal

The pre-pandemic plan was to open 10 more clinics in 2020. In addition, expansion into Malaysia and China was to be accelerated. In contrast to Germany, in Asia, dental treatments were also suspended in the event of a lockdown, and the Company had to act without further ado. It acquired a stake in Acumen Diagnostics, a manufacturer of test kits for Covid-19. The high demand was thus able to compensate for part of the shortfall but is only to play a minor supporting role in the business strategy in the future.

The Q&M Dental Group share has recently been listed on the primary stock exchange in Singapore and Germany. The stock market value is currently EUR 221 million. The strongly growing dental market in Asia and the outstanding position of the group certainly offer fantasy.

With the subsidiary on the trading floor

In the summer, news leaked out that SAP is planning to venture onto the stock market with its subsidiary Qualtrics. Qualtrics offers a software platform with which companies can collect data from customers, traders, and employees to analyze and process it in real-time. The stock market debut can happen quickly; here's how the debut's first details are coming from the Company.

"XM" is the abbreviation under which the market research Company is to be listed on the USA's Nasdaq technology exchange. Although the number of shares and the exact date are unknown, Qualtrics shares are to be sold for up to USD 24 under the aegis of investment banks Morgan Stanley and JP Morgan.

SAP retains dominance

The purchase of the analysis Company, which was completed only two years ago, was extremely lucrative. The Walldorf-based Company paid a mere USD 8.0 billion. Looking at the peer group, a doubling could well be on the books. To profit further from the technology, SAP intends to remain a majority shareholder in Qualtrics to integrate the subsidiary's features into existing SAP products.

The heavily beleaguered SAP shareholders received the news exceptionally positively. As a result, the share price jumped above the resistance level of EUR 106.00 and is working to close the share price gap at just under EUR 123.00 that opened since the horror figures.

Hand in Hand

One step further in the development of its subsidiary is the hydrogen specialist Nel ASA. The Norwegians own just under 17% of the Danish spin-off Everfuel. However, both on the stock market and fundamentally, the Company's development is going like clockwork. We already reported the tender success for a hydrogen site in Oslo and the memorandum of understanding with Green Hydrogen Hub Denmark to build a 350 MW electrolysis plant, a 200,000 MWh hydrogen facility and another energy storage facility.

The mother helps

Now Everfuel announces another deal engineered by its parent Nel ASA. The Danes are acquiring 100% of Danish Hydrogen Fuel A/S shares from former owners NelHydrogen A/S, gas producers Strandmøllen A/S and the Danish fuel company OKA. Danish Hydrogen Fuel owns and operates 4 introduced hydrogen refueling stations near the Danish cities of Korsør, Kolding, Esbjerg and Aarhus.

On the stock market, Everfuel is being celebrated as if there would be no more shares tomorrow. Since the IPO in October, the share price has risen from NOK 22 to NOK 121.20! The stock market value amounts to EUR 665.9 million. Very stately, for the still relatively small, contemplative enterprise. Investors should, however, be extremely cautious due to the low free float of a maximum of 5%.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read